EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE

Lignende værker

• Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
  af: Roger F. Butterworth, et al.
  Udgivet: (2019-03-01)
• Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
  af: Butterworth, Roger F., et al.
  Udgivet: (2018)
• Non-alcoholic Steatohepatitis: An Overview
  af: Allison Shifflet, et al.
  Udgivet: (2009-01-01)
• POSSIBILITIES TO USE L-ORNITINE-L-ASPARTATE IN THERAPY OF NON-ALCOHOL FATTY LIVER DISEASE PATIENTS
  af: L. A. Teterina, et al.
  Udgivet: (2017-11-01)
• l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
  af: Canbay, Ali, et al.
  Udgivet: (2019)